DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Banyan Bio
Banyan Bio
Institutional venture firm · probableBoston, MAbanyan-bio.comSEC exempt reporting adviseremerging manager
Banyan BioInnovations is an investment firm powered by Locust Walk that leverages global sourcing and on-the-ground presence in the US, China and Japan to create clinical-stage companies around best or first-in-class drug candidates.
venture manager with no reported fund assets yet (scale unknown)
Importance
0
low
Active deployment
0
low
Emerging
100
high
Completeness
31
moderate
Freshness
100
high
Research priority
25
moderate
Identity and regulatory footprint
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- unknown
- Business phone
- unknown
- Website
- https://www.banyan-bio.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Sep 9, 2026
- Private funds reported
- unknown
- Private fund gross assets
- unknownreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- contact@banyan-bio.combanyan-bio.compublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- biotech, medtech
- Stages
- growth, early
- Geography
- asia, boston, europe, global, globally, japan
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
0 current, 0 departed
No named professional yet. People arrive from Form ADV Schedule A (owners, officers, control persons) and the team page.
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
1 dated events
- Sep 9, 2026Banyan Bio appears on the SEC adviser roster (ERA)First SEC adviser filingOrganizationFactSEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs
Classification history
- Sep 15, 2026Institutional venture firm (probable, 70%, cls-1)venture manager with no reported fund assets yet (scale unknown)
Evidence
18 observations from 2 sources
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | vc_funds_reported | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| SEC adviser type | exempt_reporting_adviser | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| Latest Form ADV filing | 2026-09-09 | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| SEC status | ACTIVE | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| SEC status effective | 2026-09-09 | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| Description | Banyan BioInnovations is an investment firm powered by Locust Walk that leverages global sourcing and on-the-ground presence in the US, China and Japan to create clinical-stage companies around best or first-in-class drug candidates. “meta description” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Description | Banyan BioInnovations is an investment firm powered by Locust Walk that leverages global sourcing and on-the-ground presence in the US, China and Japan to create clinical-stage companies around best or first-in-class drug candidates. “meta description” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Headquarters | Boston, MA | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| Stated geography | asia,boston,europe,global,globally,japan “geography words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated geography | asia,boston,europe,global,globally,japan “geography words on the home page” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated sectors | biotech,medtech “sector words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated sectors | biotech,medtech “sector words on the home page” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated stages | growth,early “stage words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated stages | growth,early “stage words on the home page” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Venture funds reported | 1 | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| Website | https://www.banyan-bio.com/ | Sep 9, 2026 | Fact | SEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs |
| Site title | BANYAN BIOINNOVATIONS “title tag” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Site title | BANYAN BIOINNOVATIONS “title tag” | Sep 15, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |